Rezultati - Mazhari, Reza
- Showing 1 - 5 results of 5
-
1
-
2
-
3
CXL-1020, a Novel Nitroxyl (HNO) Prodrug, Is More Effective than Milrinone in Models of Diastolic Dysfunction—A Cardiovascular Therapeutic: An Efficacy and Safety Study in the Rat... od Roof, Steve R., Ueyama, Yukie, Mazhari, Reza, Hamlin, Robert L., Hartman, J. Craig, Ziolo, Mark T., Reardon, John E., del Rio, Carlos L.
Izdano 2017Text -
4
Nitroxyl (HNO) a Novel Approach for the Acute Treatment of Heart Failure od Sabbah, Hani N., Tocchetti, Carlo Gabriele, Wang, Mengjun, Daya, Samantapudi, Gupta, Ramesh C., Tunin, Richard S., Mazhari, Reza, Takimoto, Eiki, Paolocci, Nazareno, Cowart, Douglas, Colucci, Wilson S., Kass, David A.
Izdano 2013Text -
5
Preclinical pharmacology and pharmacokinetics of CERC‐301, a GluN2B‐selective N‐methyl‐D‐aspartate receptor antagonist od Garner, Rachel, Gopalakrishnan, Shobha, McCauley, John A., Bednar, Rodney A., Gaul, Stanley L., Mosser, Scott D., Kiss, Laszlo, Lynch, Joseph J., Patel, Shil, Fandozzi, Christine, Lagrutta, Armando, Briscoe, Richard, Liverton, Nigel J., Paterson, Blake M., Vornov, James J., Mazhari, Reza
Izdano 2015Text